Shopping Cart
Remove All
Your shopping cart is currently empty
REGN5678 is a bispecific antibody that targets both PSMA on prostate cancer cells and CD28 on T cells, enhancing immune activation. This drug is being developed to treat prostate cancer by redirecting T cells to tumors expressing PSMA, thereby promoting tumor cell death. Its molecular weight is 145.86 kDa.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | REGN5678 is a bispecific antibody that targets both PSMA on prostate cancer cells and CD28 on T cells, enhancing immune activation. This drug is being developed to treat prostate cancer by redirecting T cells to tumors expressing PSMA, thereby promoting tumor cell death. Its molecular weight is 145.86 kDa. |
| Synonyms | Regn5678 (Anti-CD28 & PSMA), Regn5678, Nezastomig |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 2657613-60-8 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.